<DOC>
	<DOC>NCT01184001</DOC>
	<brief_summary>In this study, a 10 mg tasocitinib (CP-690,550) tablet will be administered to healthy subjects on two separate dosing occasions. On one occasion the tasocitinib (CP-690,550) tablet will be administered in a fasting condition; On the other occasion the tasocitinib (CP-690,550) tablet will be administered in a fed condition following a standard breakfast meal. The amount of tasocitinib (CP-690,550) in the blood will be measured at various times over 24 hours following each dosing occasion and compared to evaluate for any differences.</brief_summary>
	<brief_title>A Study To Evaluate The Effect Of Food On How Tasocitinib (CP-690,550) Is Absorbed And Moves Through The Body Following Oral Administration Of Tasocitinib (CP-690,550) Tablets To Healthy Subjects</brief_title>
	<detailed_description>To evaluate the effect of food on the pharmacokinetics of tasocitinib (CP-690,550).</detailed_description>
	<mesh_term>Arthritis, Rheumatoid</mesh_term>
	<mesh_term>Tofacitinib</mesh_term>
	<criteria>Healthy male and/or female (nonchildbearing potential) subjects between the ages of 21 and 55 years. Body Mass Index (BMI) of 17.5 to 30.5 kg/m2; and a total body weight for males&gt;50 kg (110 lbs). For females, total body weight &gt;45 kg (99 lbs). No evidence of active or latent or inadequately treated infection with Mycobacterium tuberculosis (TB) Evidence or history of any clinically significant illness, medical condition, or disease. Evidence or history of any clinically significant infections within the past 3 months. Use of tobacco or nicotinecontaining products in excess of the equivalent of 5 cigarettes per day.</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>Healthy subjects</keyword>
	<keyword>Food Effect Study</keyword>
</DOC>